SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹18 Cr | ₹17 Cr | ₹1.33 Cr | ₹-1.73 Cr | ₹-5.41 Cr |
What is the latest Net Current Assets ratio of SOTAC PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹17 Cr |
| Mar2023 | ₹1.33 Cr |
| Mar2022 | ₹-1.73 Cr |
| Mar2021 | ₹-5.41 Cr |
How is Net Current Assets of SOTAC PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | 8.06 | |
| Mar2024 | ₹17 Cr | 1,174.68 | |
| Mar2023 | ₹1.33 Cr | Positive | |
| Mar2022 | ₹-1.73 Cr | Negative | |
| Mar2021 | ₹-5.41 Cr | - | |
Compare Net Current Assets of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹111.0 Cr | -4.8% | -2% | -17.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -4.8% |
-2% |
-17.6% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses